-
Edifecs Announces Acquisition of Talix
BELLEVUE, Wash.–(BUSINESS WIRE)–Edifecs, Inc., a health information technology solutions company, announced today that it has acquired Talix, an information technology company that provides risk and quality solutions to healthcare payers and providers. The integration of Edifecs’ and Talix’s technologies will create an expanded risk adjustment solution with critical workflows and insights that improve efficiencies and directly support payer and provider collaboration. “The more we learned about Talix, the more impressed we were with the company, their leadership team, and their patent-awarded technology,” said Venkat Kavarthapu, CEO of Edifecs. “Talix has deep NLP capabilities in the industry with … Read more
-
Edifecs Announces Acquisition of Talix | Business
BELLEVUE, Wash.–(BUSINESS WIRE)–Sep 13, 2021– Edifecs, Inc., a health information technology solutions company, announced today that it has acquired Talix, an information technology company that provides risk and quality solutions to healthcare payers and providers. The integration of Edifecs’ and Talix’s technologies will create an expanded risk adjustment solution with critical workflows and insights that improve efficiencies and directly support payer and provider collaboration. “The more we learned about Talix, the more impressed we were with the company, their leadership team, and their patent-awarded technology,” said Venkat Kavarthapu, CEO of Edifecs. “Talix has deep NLP capabilities in the industry … Read more
-
Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange
Common stock and warrants of the combined company, renamed Renovacor, Inc., will commence trading on September 3, 2021 on the NYSE under ticker symbols “RCOR” and “RCOR.WS”, respectively. Gross proceeds from the transaction totaled approximately $95.1 million. PHILADELPHIA, September 02, 2021–(BUSINESS WIRE)–Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology company developing adeno-associated virus (AAV)‑based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants, today announced the closing of its previously announced business combination with Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) (“CHAQ”), a special purpose acquisition company sponsored by Chardan Capital Markets (“Chardan”). … Read more
-
Genome Medical Announces Acquisition of GeneMatters and Closing of $60 Million Series C Financing
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genome Medical, the leading nationwide genomic care delivery company, today announced that it will acquire GeneMatters, a telehealth genetic counseling and software solutions company. Simultaneously, the company announced the closing of a $60 million Series C financing to accelerate commercial traction and advance its mission of transforming health care for all through genomic medicine. These strategic initiatives solidify its position as the preeminent technology-enabled provider of genetic health services and genomic insights. “The addition of GeneMatters, along with our Series C financing, propels us into the next phase of commercial growth and … Read more
